Literature DB >> 28622299

A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation.

Qi Yang1,2, William W Du1,2, Nan Wu1,2, Weining Yang1, Faryal Mehwish Awan1,2, Ling Fang1,2,3, Jian Ma1,2, Xiangmin Li1,2, Yan Zeng1,2, Zhenguo Yang1,2, Jun Dong1,2, Azam Khorshidi1,2, Burton B Yang1,2,4.   

Abstract

Circular RNAs (circRNAs) are a subclass of noncoding RNAs widely expressed in mammalian cells. We report here the tumorigenic capacity of a circRNA derived from angiomotin-like1 (circ-Amotl1). Circ-Amotl1 is highly expressed in patient tumor samples and cancer cell lines. Single-cell inoculations using circ-Amotl1-transfected tumor cells showed a 30-fold increase in proliferative capacity relative to control. Agarose colony-formation assays similarly revealed a 142-fold increase. Tumor-take rate in nude mouse xenografts using 6-day (219 cells) and 3-day (9 cells) colonies were 100%, suggesting tumor-forming potential of every cell. Subcutaneous single-cell injections led to the formation of palpable tumors in 41% of mice, with tumor sizes >1 cm3 in 1 month. We further found that this potent tumorigenicity was triggered through interactions between circ-Amotl1 and c-myc. A putative binding site was identified in silico and tested experimentally. Ectopic expression of circ-Amotl1 increased retention of nuclear c-myc, appearing to promote c-myc stability and upregulate c-myc targets. Expression of circ-Amotl1 also increased the affinity of c-myc binding to a number of promoters. Our study therefore reveals a novel function of circRNAs in tumorigenesis, and this subclass of noncoding RNAs may represent a potential target in cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28622299      PMCID: PMC5563992          DOI: 10.1038/cdd.2017.86

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  50 in total

1.  Pluripotency redux--advances in stem-cell research.

Authors:  John Gearhart; Evanthia E Pashos; Megana K Prasad
Journal:  N Engl J Med       Date:  2007-10-11       Impact factor: 91.245

2.  Detecting and characterizing circular RNAs.

Authors:  William R Jeck; Norman E Sharpless
Journal:  Nat Biotechnol       Date:  2014-05       Impact factor: 54.908

3.  Circular RNAs are a large class of animal RNAs with regulatory potency.

Authors:  Sebastian Memczak; Marvin Jens; Antigoni Elefsinioti; Francesca Torti; Janna Krueger; Agnieszka Rybak; Luisa Maier; Sebastian D Mackowiak; Lea H Gregersen; Mathias Munschauer; Alexander Loewer; Ulrike Ziebold; Markus Landthaler; Christine Kocks; Ferdinand le Noble; Nikolaus Rajewsky
Journal:  Nature       Date:  2013-02-27       Impact factor: 49.962

4.  A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223.

Authors:  Kun Wang; Bo Long; Fang Liu; Jian-Xun Wang; Cui-Yun Liu; Bing Zhao; Lu-Yu Zhou; Teng Sun; Man Wang; Tao Yu; Ying Gong; Jia Liu; Yan-Han Dong; Na Li; Pei-Feng Li
Journal:  Eur Heart J       Date:  2016-01-21       Impact factor: 29.983

5.  NCLscan: accurate identification of non-co-linear transcripts (fusion, trans-splicing and circular RNA) with a good balance between sensitivity and precision.

Authors:  Trees-Juen Chuang; Chan-Shuo Wu; Chia-Ying Chen; Li-Yuan Hung; Tai-Wei Chiang; Min-Yu Yang
Journal:  Nucleic Acids Res       Date:  2015-10-05       Impact factor: 16.971

6.  Circular intronic long noncoding RNAs.

Authors:  Yang Zhang; Xiao-Ou Zhang; Tian Chen; Jian-Feng Xiang; Qing-Fei Yin; Yu-Hang Xing; Shanshan Zhu; Li Yang; Ling-Ling Chen
Journal:  Mol Cell       Date:  2013-09-12       Impact factor: 17.970

7.  The pseudogene TUSC2P promotes TUSC2 function by binding multiple microRNAs.

Authors:  Zina Jeyapalan Rutnam; William W Du; Weining Yang; Xiangling Yang; Burton B Yang
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

8.  RNABindRPlus: a predictor that combines machine learning and sequence homology-based methods to improve the reliability of predicted RNA-binding residues in proteins.

Authors:  Rasna R Walia; Li C Xue; Katherine Wilkins; Yasser El-Manzalawy; Drena Dobbs; Vasant Honavar
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

9.  Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor.

Authors:  Yehoshua Enuka; Mattia Lauriola; Morris E Feldman; Aldema Sas-Chen; Igor Ulitsky; Yosef Yarden
Journal:  Nucleic Acids Res       Date:  2015-12-10       Impact factor: 16.971

10.  Circular RNAs and their associations with breast cancer subtypes.

Authors:  Asha A Nair; Nifang Niu; Xiaojia Tang; Kevin J Thompson; Liewei Wang; Jean-Pierre Kocher; Subbaya Subramanian; Krishna R Kalari
Journal:  Oncotarget       Date:  2016-12-06
View more
  124 in total

1.  Research progress on circularRNAs in pancreatic cancer: emerging but promising.

Authors:  Yi-Zhi Wang; Yang An; Bing-Qi Li; Jun Lu; Jun-Chao Guo
Journal:  Cancer Biol Ther       Date:  2019-05-28       Impact factor: 4.742

Review 2.  A 360° view of circular RNAs: From biogenesis to functions.

Authors:  Jeremy E Wilusz
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-14       Impact factor: 9.957

Review 3.  Guidance of circular RNAs to proteins' behavior as binding partners.

Authors:  Junyun Luo; Hui Liu; Siyu Luan; Zhaoyong Li
Journal:  Cell Mol Life Sci       Date:  2019-07-03       Impact factor: 9.261

Review 4.  Circular RNAs: A Novel Class of Functional RNA Molecules with a Therapeutic Perspective.

Authors:  Laura Santer; Christian Bär; Thomas Thum
Journal:  Mol Ther       Date:  2019-07-09       Impact factor: 11.454

Review 5.  Progress in Understanding the Relationship Between Circular RNAs and Neurological Disorders.

Authors:  Qunhui Wang; Lai Qu; Xuan Chen; Yu-Hao Zhao; Qi Luo
Journal:  J Mol Neurosci       Date:  2018-08-01       Impact factor: 3.444

6.  TWIST1 regulation of circRNA: a novel mechanism to promote epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Zachary A Yochum; Timothy F Burns
Journal:  Noncoding RNA Investig       Date:  2018-12-19

Review 7.  Circular RNAs: pivotal molecular regulators and novel diagnostic and prognostic biomarkers in non-small cell lung cancer.

Authors:  Chunyan Li; Lin Zhang; Guangping Meng; Qi Wang; Xuejiao Lv; Jie Zhang; Junyao Li
Journal:  J Cancer Res Clin Oncol       Date:  2019-10-19       Impact factor: 4.553

8.  A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy.

Authors:  William W Du; Weining Yang; Xiangmin Li; Faryal Mehwish Awan; Zhenguo Yang; Ling Fang; Juanjuan Lyu; Feiya Li; Chun Peng; Sergey N Krylov; Yizhen Xie; Yaou Zhang; Chengyan He; Nan Wu; Chao Zhang; Mouna Sdiri; Jun Dong; Jian Ma; Chunqi Gao; Steven Hibberd; Burton B Yang
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

Review 9.  Non-coding RNAs: the new central dogma of cancer biology.

Authors:  Phei Er Saw; Xiaoding Xu; Jianing Chen; Er-Wei Song
Journal:  Sci China Life Sci       Date:  2020-09-11       Impact factor: 6.038

10.  Ganoderiol F purified from Ganoderma leucocontextum retards cell cycle progression by inhibiting CDK4/CDK6.

Authors:  Xiangmin Li; Yizhen Xie; Juanjuan Peng; Huiping Hu; Qingping Wu; Burton B Yang
Journal:  Cell Cycle       Date:  2019-09-22       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.